feed,title,long_url,short_url
Benzinga,Ovid Therapeutics Stops Gaboxadol Development Citing Limited Efficacy In Rare Neurological Conditions,https://benzinga.com/general/biotech/21/04/20680334/ovid-therapeutics-stops-gaboxadol-development-citing-limited-efficacy-in-rare-neurological-condit,https://j.mp/2QG9zIj
